Suramin inhibits osteoarthritic cartilage degradation by increasing extracellular levels of chondroprotective tissue inhibitor of metalloproteinases 3 (TIMP-3)

Osteoarthritis is a common degenerative joint disease for which no disease-modifying drugs are currently available. Attempts to treat the disease with small molecule inhibitors of the metalloproteinases that degrade the cartilage matrix have been hampered by a lack of specificity. We aimed to inhibi...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors: Chanalaris, A, Doherty, C, Marsden, B, Bambridge, G, Wren, S, Nagase, H, Troeberg, L
Format: Journal article
Udgivet: American Society for Pharmacology and Experimental Therapeutics 2017

Lignende værker